Tailored PEG for rh-G-CSF analogue site-specific conjugation

Bioconjugate Chemistry

Volumn 20, Issue 6, 2009, Pages 1179-1185

  Salmaso, Stefano ^b   Bersani, Sara ^b   Scomparin, Anna ^b   Mastrotto, Francesca ^b   Scherpfer, Rodolfo ^b   Tonon, Giancarlo ^b   Caliceti, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GUANIDINE DERIVATIVE; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CIRCULAR DICHROISM; COLORIMETRY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONJUGATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PH MEASUREMENT; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 67649206333     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9000432     Document Type: Article

References (32)

1. Harris, M. J., and Chess, R. B. (2003) Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discovery 2, 214-221. (Pubitemid 37361666)
2. Kozlowski, A., and Harris, J. M. (2001) Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C. J. Controlled Release 72, 217-224 (Pubitemid 32522359)
3. Salmaso, S., Bersani, S., Semenzato, A., and Caliceti, P. (2006) Nanotechnologies in protein delivery. J. Nanosci. Nanotechnol. 6, 2736-2753 (Pubitemid 44579942)
4. Mehvar, R. (2000) Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation. J. Pharm. Sci. 3, 125-136
5. Bailon, P., and Berthold, W. (1998) Polyethylene glycolconjugated pharmaceutical proteins. PSTT 1, 352-356.
6. Bowen, S., Tare, N., Inoue, T., Yamasaki, M., Okabe, M., Horii, I., and Eliason, J. F. (1999) Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Exp. Hematol. 27, 425-432 (Pubitemid 29125050)
7. Sato, H. (2002) Enzymatic procedure for site-specific pegylation of proteins. Adv. Drug Delivery Rev. 54, 487-504. (Pubitemid 34615545)
8. Roberts, M. J., Bentley, M. D., and Harris, J. M. (2002) Chemistry for peptide and protein PEGylation. Adv. Drug Delivery Rev. 54, 459-476.
9. Brocchini, S., Godwin, A., Balan, S., Choi, J., Zloh, M., and Shaunak, S. (2008) Disulfide bridge based PEGylation of proteins. Adv. Drug Delivery Rev. 60, 3-12.
10. Anderlini, P., Przepiorka, D., Champlin, R., and Korbling, M. (1996) Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88, 2819-2825. (Pubitemid 26357361)
11. Welte, K., Gabrilove, J., Bronchud, M. H., Platzer, E., and Morstyn, G. (1996) Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88, 1907-1929. (Pubitemid 26307891)
12. Ricci, M. S., Sarkar, C. A., Fallon, E. M., Lauffenburger, D. A., and Brems, D. N. (2003) pH dependence of structural stability of interleukin-2 and granulocyte colony-stimulating factor. Protein Sci. 12, 1030-1038. (Pubitemid 36505437)
13. Tanaka, H., Satake-Ishikawa, R., Ishikawa, M., Matsuki, S., and Asano, K. (1991) Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats. Cancer Res. 51, 3710-3714.
14. Layton, J. E., Morstyn, G., Fabri, L. J., Reid, G. E., Burgess, A. W., Simpson, R. J., and Nice, E. C. (1991) Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodies. J. Biol. Chem. 266, 23815-23823. (Pubitemid 21908870)
15. Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., and Treuheit, M. J. (1996) Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 13, 996-1002. (Pubitemid 26258997)
16. Molineux, G., Kinstler, O., Briddell, B., Hartley, C., McElroy, P., Kerzic, P., Sutherland, W., Stoney, G., Kern, B., Fletcher, F. A., Cohen, A., Korach, E., Ulich, T., McNiece, I., Lockbaum, P., Miller-Messana, M. A., Gardner, S., Hunt, T., and Schwab, G. (1999) A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp. Hematol. 27, 1724-1734.
17. Snyder, S. L., and SoBocinsky, P. Z. (1975) An improved 2,4,6-trinitroben-nesulphonic acid method for the determination of amines. Anal. Biochem. 64, 284-288.
18. Habeeb, A. F. S. A. (1966) Anal. Biochem. 14, 328-336.
19. Riddles, P. W., Blakeley, R. L., and Zerner, B. (1979) Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid): a rexamination. Anal. Biochem. 94, 75-81. (Pubitemid 9170207)
20. Sims, G. E. C., and Snape, T. J. (1980) A method for estimation of poly(ethylene glycol) in plasma protein fractions. Anal. Biochem. 107, 60-63. (Pubitemid 11196629)
21. Koike, M., Ishiyama, T., Tomoyasu, S., and Tsuruoka, N. (1995) Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia. Leukemia Res. 19, 639-644.
22. Fujii, I., Nagahara, Y., Yamasaki, M., Yokoo, Y., Itoh, S., and Hirayama, N. (1997) Structure of KW-2228, a tailored human granulocyte colony-stimulating factor with enhanced biological activity and stability. FEBS Lett. 410, 131-135 (Pubitemid 27304050)
23. Veronese, F. M., Monfardini, C., Caliceti, P., Schiavon, O., Scrawen, M. D., and Beer, D. (1996) Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol). J. Controlled Release 40, 199-209. (Pubitemid 26238372)
24. Caliceti, P., and Veronese, F. M. (2003) Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv. Drug Delivery Rev. 55, 1261-1277. (Pubitemid 37464561)
25. Molineux, G. (2003) Pegylation: engineering improved biopharmaceuticals for oncology. Pharmacotherapy 23, 3S-8S.
26. Molineux, G. (2004) The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta). Curr. Pharm. Des. 10, 1235-1244 (Pubitemid 38425903)
27. Hill, C. P., Osslund, T. D., and Eisenberg, D. (1993) The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Biochemistry 90, 5167-5171. (Pubitemid 23182998)
28. Brems, D. N. (2002) The kinetics of G-CSF folding. Protein Sci. 11, 2504-2511. (Pubitemid 35050675)
29. Tsubery, H., Mironchik, M., Fridkin, M., and Shechter, Y. (2004) Prolonging the action of protein and peptide drugs by a novel approach of reversible polyethylene glycol modification. J. Biol. Chem. 279, 38118-38124. (Pubitemid 39295957)
30. Raso, S. W., Abel, J., Barnes, J. M., Maloney, K. M., Pipes, G., Treuheit, M. J., King, J., and Brems, D. N. (2005) Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci. 14, 2246-2257. (Pubitemid 41252793)
31. Miller, K. E., and Synovec, R. E. (2000) Rapid polymeric surfactant characterization using a novel flow-injection system with dynamic surface tension detection. Anal. Chim. Acta 412, 149-160. (Pubitemid 30173271)
32. Narhi, L. O., Kenney, W. C., and Arakawa, T. (1991) Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride. J. Protein Chem. 10, 359-367.